Whitney George
Physician Assistant · Avondale, AZNPI 1639834989
Payments from drug & device makers
Across 153 payments — averaging $22.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$686
- AstraZeneca$323
- Dexcom, Inc.$272
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$252
- GSK$219
- Novo Nordisk$213
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,469100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $686 |
| AstraZeneca | 7 | $323 |
| Dexcom, Inc. | 10 | $272 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $252 |
| GSK | 12 | $219 |
| Novo Nordisk | 7 | $213 |
| Boehringer Ingelheim | 7 | $143 |
| Sanofi-aventis U.S. LLC | 2 | $138 |
| Abbott | 6 | $128 |
| Optinose US, Inc. | 1 | $99 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Amgen | 5 | $83 |
| Lilly USA, LLC | 3 | $77 |
| Vanda Pharmaceuticals Inc. | 2 | $64 |
| Astellas Pharma US Inc | 3 | $63 |
| Bayer | 3 | $60 |
| Corcept Therapeutics | 2 | $51 |
| Johnson & Johnson(2 entities) | 2 | $43 |
| Lundbeck LLC | 2 | $37 |
| Hologic Sales And Service, LLC | 2 | $35 |
| Abiomed | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| Shield Therapeutics Inc | 1 | $33 |
| Inspire Medical Systems, Inc. | 2 | $33 |
| Tonix Medicines, Inc. | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 2 | $27 |
| Alnylam Pharmaceuticals Inc. | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Edwards Lifesciences | 1 | $25 |
| Pfizer | 1 | $24 |
| Medtronic | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Phadia US Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$231
- SOLIQUA 100/33$125
- Ozempic$119
- UBRELVY$117
- VRAYLAR$102
How this compares
$3,469 in reported general payments places this provider in the 85th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 102 | $101,338 |
| TrulicityDulaglutide | 36 | $45,880 |
| FarxigaDapagliflozin Propanediol | 39 | $44,730 |
| JardianceEmpagliflozin | 30 | $37,581 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $35,730 |
| LinzessLinaclotide | 35 | $35,118 |
| MounjaroTirzepatide | 26 | $30,035 |
| VraylarCariprazine Hcl | 19 | $28,986 |
| EliquisApixaban | 31 | $24,781 |
| XareltoRivaroxaban | 14 | $12,349 |
| EntrestoSacubitril/Valsartan | 13 | $8,975 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $4,396 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 37 | $3,115 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 85 | $2,821 |
| DilantinPhenytoin Sodium Extended | 12 | $2,279 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $213 | $101,338102 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $77 | $75,91662 claims |
| AbbVieLinzess, Vraylar | $686 | $64,10454 claims |
| AstraZenecaFarxiga | $323 | $44,73039 claims |
| Boehringer IngelheimJardiance | $143 | $37,58130 claims |
| GSKTrelegy Ellipta | $219 | $35,73029 claims |
| PfizerEliquis, Dilantin | $24 | $27,05943 claims |
| Johnson & JohnsonXarelto | $43 | $12,34914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Avondale
- Eric OvalleAvondale$13K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
- Nicole StokerTucson$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.